https://scholars.lib.ntu.edu.tw/handle/123456789/641431
標題: | The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment | 作者: | Hou, Yi-Chou Chueh, Ti-I Lu, Kuo-Cheng Liu, Yi-Chien Chen, Tso-Hsiao SHING-HWA LIU Chen, Ruei-Ming |
關鍵字: | Albumin; Alzheimer’s disease; amyloid-beta 1-42; biomarker signature; cognitive impairment; end-stage renal disease | 公開日期: | 2024 | 出版社: | IOS Press BV | 卷: | 97 | 期: | 3 | 起(迄)頁: | 1393-1405 | 來源出版物: | Journal of Alzheimer's Disease | 摘要: | Cognitive impairment (CI) is one of the major complications in chronic kidney disease patients, especially those with end-stage renal disease (ESRD). Limited biomarkers have been found that can significantly predict ESRD-associated cognitive decline. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641431 | ISSN: | 13872877 18758908 |
DOI: | 10.3233/JAD-230747 |
顯示於: | 毒理學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。